ＣＤ３３抗体及び癌を処置するためのその使用

Title:

ＣＤ３３抗体及び癌を処置するためのその使用

Document Type and Number:

Japanese Patent JP6454269

Kind Code:

B2

Abstract:

The invention provides murine, chimeric, and humanized antibodies that specifically bind to CD33. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting CD33.

More Like This:

WO/2002/077233	38650, 28472, 5495, 65507, 81588 and 14354 METHODS AND COMPOSITIONS OF HUMAN PROTEINS AND USES THEREOF
WO/1994/004188	METHOD FOR TREATING AN LFA-1-MEDIATED DISORDER
JP2022532991	Monoclonal antibody that specifically binds to GITR

Inventors:

Sutherland, Mayn
Ryan, Maureen
Sassman, Giango
Bark, patrick
Jeffrey, Scott

Application Number:

JP2015512801A

Publication Date:

January 16, 2019

Filing Date:

May 15, 2013

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Seattle Genetics, Incorporated

International Classes:

C07K16/28; A61K31/5517; A61K39/395; A61P35/00; A61P35/02; A61P43/00; C07K16/46; C12N15/13

Domestic Patent References:

JP2012505871A
JP2006505277A

Foreign References:

WO2008070593A1
WO2011130613A1

Attorney, Agent or Firm:

Yusuke Hiraki
Satoshi Fujita
Eiichi Arai
Natsuo Tanaka
Naoko Kikuta
Wataru Ueda

Previous Patent: 硬化性樹脂組成物

Next Patent: INTEGRATION TYPE POLYPHASE WATTMETER